by Avi Kapoor | Mar 27, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BTIG analyst Gregory Lewis initiated coverage on Iperionx Ltd...
by Avi Kapoor | Mar 27, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Barclays analyst Glen Santangelo upgraded Phathom Pharmaceuticals...
by Eva Mathew | Mar 27, 2026 | General
The Iran war has already set the stage for elevated petrochemical prices through year-end, and the supply chain damage could take the better part of a year to unwind, Dow chairman and CEO Jim Fitterling said. Speaking at the CERAWeek by S&P Global conference in...
by Vandana Singh | Mar 27, 2026 | General
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) shares are up during Friday’s premarket session following the FDA’s accelerated approval of Kresladi (marnetegragene autotemcel), the first gene therapy for children with severe leukocyte adhesion deficiency-I (LAD-I). FDA...
by Kaustubh Bagalkote | Mar 27, 2026 | General
Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) shares fell in Friday’s premarket session. This follows a 3.44% decline during Thursday’s regular trading. The tech giant faces a combination of courtroom setbacks and broader macroeconomic pressures. Nasdaq futures are down...
Recent Comments